432 related articles for article (PubMed ID: 27397679)
1. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
[TBL] [Abstract][Full Text] [Related]
4. [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].
Jiang H; Cheng QF; Zhu BZ; Yang Q
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):977-982. PubMed ID: 34814392
[No Abstract] [Full Text] [Related]
5. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
[TBL] [Abstract][Full Text] [Related]
8. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
[TBL] [Abstract][Full Text] [Related]
9. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition.
Peng TC; Wu LW; Chen WL; Liaw FY; Chang YW; Kao TW
Clin Nutr; 2019 Feb; 38(1):422-428. PubMed ID: 29287676
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
[TBL] [Abstract][Full Text] [Related]
13. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography.
Tanaka M; Okada H; Hashimoto Y; Kumagai M; Nishimura H; Oda Y; Fukui M
Liver Int; 2020 Jan; 40(1):120-130. PubMed ID: 31518481
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
15. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent changes in skeletal muscle mass and visceral fat area in Japanese adults from 40 to 79 years-of-age.
Yamada M; Moriguch Y; Mitani T; Aoyama T; Arai H
Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():8-14. PubMed ID: 24450556
[TBL] [Abstract][Full Text] [Related]
18. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease.
Rigor J; Vasconcelos R; Lopes R; Moreira T; Barata P; Martins-Mendes D
Minerva Gastroenterol (Torino); 2023 Sep; 69(3):374-381. PubMed ID: 35343663
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture.
Hida T; Ishiguro N; Shimokata H; Sakai Y; Matsui Y; Takemura M; Terabe Y; Harada A
Geriatr Gerontol Int; 2013 Apr; 13(2):413-20. PubMed ID: 22816427
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Ciminnisi S; Di Marco V; Cabibi D; Cammà C; Licata A; Marchesini G; Craxì A
Aliment Pharmacol Ther; 2017 Feb; 45(4):510-518. PubMed ID: 28028821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
